Catalyst event

Moderna Inc (MRNA)

From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)

The FDA is scheduled to issue its PDUFA decision on Moderna's mRNA-1010 seasonal influenza vaccine on August 5, 2026.

Korean translation

FDA가 2026년 8월 5일 모더나의 계절성 독감 백신 mRNA-1010에 대한 PDUFA 결정을 내릴 예정임.